CTRI/2021/08/035789尚未招募未知
Prospective, Prescription Event Monitoring (PEM) surveillance of EMROK® (Levonadifloxacin injection) &/or EMROK â?? O® (Levonadifloxacin tablet)
Wockhardt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adult patients of any gender who have been prescribed with EMROK® or EMROK â?? O® by their treating physicians can be part of this prescription event monitoring surveillance
排除标准
- •1. Known to be hypersensitive to Levonadifloxacin and any other quinolone antibactrial or to any other excepients
- •2. Patients having history of Tendon disorders
研究者
相似试验
尚未招募
4 期
Real world study to evaluate the safety and efficacy of NUWOK tab and Injection in the patients have infection.CTRI/2024/04/065903Wockhardt Ltd
尚未招募
4 期
Prescription event monitoring study of Emrok injection and tabin the patient of diabetes foot ulcer.CTRI/2024/04/065615Wockhardt Ltd
已完成
不适用
Real world data of patients across India will be retrospectively collected in this study of Levonadifloxacin.CTRI/2020/09/028152Wockhardt Limited
尚未招募
4 期
To evaluate the safety and efficacy of Emrok tablet and Emrok Injection by the surveillance study.CTRI/2023/09/057485Wockhardt Ltd
尚未招募
4 期
To Effects of ZincorespTM Syrup in Children Aged 2- 12 Years Having Respiratory Disorders and Infections.CTRI/2024/02/063048apex laboratories private limited